| Metabolic effects of dialyzate glucose in chronic hemodialysis: results from a prospective, randomized crossover trial. | |
| | |
MedLine Citation:
|
PMID: 21940484 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: There is no agreement concerning dialyzate glucose concentration in hemodialysis (HD) and 100 and 200 mg/dL (G100 and G200) are frequently used. G200 may result in diffusive glucose flux into the patient, with consequent hyperglycemia and hyperinsulinism, and electrolyte alterations, in particular potassium (K) and phosphorus (P). This trial compared metabolic effects of G100 versus G200.METHODS: Chronic HD patients participated in this randomized, single masked, controlled crossover trial (www.clinicaltrials.gov: #NCT00618033) consisting of two consecutive 3-week segments with G100 and G200, respectively. Intradialytic serum glucose (SG) and insulin concentrations (SI) were measured at 0, 30, 60, 120, 180, 240 min and immediately post-HD; P and K were measured at 0, 120, 180 min and post-HD. Hypoglycemia was defined as an SG <70 mg/dL. Mean SG and SI were computed as area under the curve divided by treatment time.RESULTS: Fourteen diabetic and 15 non-diabetic subjects were studied. SG was significantly higher with G200 as compared to G100, both in diabetic {G200: 192.8 ± 48.1 mg/dL; G100: 154.0 ± 27.3 mg/dL; difference 38.8 [95% confidence interval (CI): 21.2-56.4] mg/dL; P < 0.001} and non-diabetic subjects [G200: 127.0 ± 11.2 mg/dL; G100 106.5 ± 10.8 mg/dL; difference 20.6 (95% CI: 15.3-25.9) mg/dL; P < 0.001]. SI was significantly higher with G200 in non-diabetic subjects. Frequency of hypoglycemia, P and K serum levels, interdialytic weight gain and adverse intradialytic events did not differ significantly between G100 and G200.CONCLUSION: G200 may exert unfavorable metabolic effects in chronic HD patients, in particular hyperglycemia and hyperinsulinism, the latter in non-diabetic subjects. |
| | |
Authors:
|
Jochen G Raimann; Anja Kruse; Stephan Thijssen; Viktoriya Kuntsevich; Pascal Dabel; Mostafa Bachar; Jose A Diaz-Buxo; Nathan W Levin; Peter Kotanko |
Related Documents
:
|
11921494 - The effects of valsartan on insulin sensitivity in patients with primary hypertension. 18239564 - Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic su... 14564674 - Platelet count is independently associated with insulin resistance in non-obese japanes... 16437664 - Serum insulin, insulin resistance, beta-cell dysfunction, and gallstone disease among t... 15955124 - The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese ins... 8556064 - A study of effect of cs-045, a new antidiabetic drug, on hypertension in spontaneously ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-22 |
Journal Detail:
|
Title: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Volume: - ISSN: 1460-2385 ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-9-23 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8706402 Medline TA: Nephrol Dial Transplant Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1Renal Research Institute, New York City, NY, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
Next Document: High-dose steroid treatment increases free water transport in peritoneal dialysis patients.